retatrutide triple agonist clinical trial A new from Eli Lilly and Company suggests its experimental hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes ๐จ HOT OFF THE PRESS:
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 22 - Aug 27


























